{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CLD"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLD\",,,,,undefined,":{"symbol":"CLD","market":"US","secType":"STK","nameCN":"Cloud Peak","latestPrice":0.1565,"timestamp":1553889600000,"preClose":0.1565,"halted":3,"volume":0,"delay":0,"floatShares":58447153,"shares":73169272,"eps":-9.49,"marketStatus":"Halted","change":0,"latestTime":"05-21 09:01:29 EDT","open":0.1565,"high":0.1565,"low":0.1565,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.49,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747834200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1258693200000,"exchange":"NYSE","adjPreClose":0.1565,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLD\",,,,,undefined,":{"symbol":"CLD","floatShares":58447153,"roa":"--","roe":"--","lyrEps":-9.488706,"shares":73169272,"dividePrice":0,"high":0.1565,"amplitude":0,"preClose":0.1565,"low":0.1565,"week52Low":0.1505,"pbRate":"0.04","week52High":4.1,"institutionHeld":0,"latestPrice":0.1565,"eps":-9.49,"divideRate":0,"volume":0,"delay":0,"ttmEps":-9.49,"open":0.1565,"prevYearClose":0.1565},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CLD\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLD\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2301384462","title":"Press Release: FDA accepts nirsevimab application as first protective option against RSV disease for all infants","url":"https://stock-news.laohu8.com/highlight/detail?id=2301384462","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2301384462?lang=en_us&edition=fundamental","pubTime":"2023-01-05 15:00","pubTimestamp":1672902000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-fda-accepts-nirsevimab-070000942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4018","BK4585","BK4196","BK4007","CHD","AMED","BK4214","BK4504","CLD","SNY","AAP","CDC"],"gpt_icon":0},{"id":"2280757334","title":"Press Release: European Commission grants first approval worldwide of Beyfortus® (nirsevimab) for prevention of RSV disease in infants","url":"https://stock-news.laohu8.com/highlight/detail?id=2280757334","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2280757334?lang=en_us&edition=fundamental","pubTime":"2022-11-04 15:00","pubTimestamp":1667545200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-european-commission-grants-070000066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHD","CHMP","CLD","SNY","BK4087","AMED","BK4018","BK4196","BK4504","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-10-25","symbol":"CLD","fiscalQuarterEnding":"2018/09","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1540440000000,"reportTimeType":"post","actualEps":0.16},{"market":"US","date":"2018-07-26","symbol":"CLD","fiscalQuarterEnding":"2018/06","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1532577600000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2018-04-26","symbol":"CLD","fiscalQuarterEnding":"2018/03","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1524715200000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2018-02-15","symbol":"CLD","fiscalQuarterEnding":"2017/12","expectedEps":-0.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1518670800000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2017-10-26","symbol":"CLD","fiscalQuarterEnding":"2017/09","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1508990400000,"reportTimeType":"post","actualEps":0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLD\",market:\"US\",delay:false,,,undefined,":{}}}